why choose us

First received: May 12, 2026

Clinical Trial: A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, OPEN LABEL, SINGLE DOSE, RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF TWO FORMULATIONS OF A CGRP RECEPTOR ANTAGONIST IN HEALTHY ADULT PARTICIPANTS

Brief Summary: The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.

Read more